Crédit Industriel et Commercial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Crédit Industriel et Commercial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Sell	11,590 -24,043	-67%	-$3.25M	0.12%	160
2026 Q1	$4.55M	Buy	35,633 +16,656	+88%	+$2.08M	0.35%	77
2025 Q4	$2.31M	Sell	18,977 -4,927	-21%	-$565K	0.18%	130
2025 Q3	$2.4M	Sell	23,904 -26,896	-53%	-$2.42M	0.2%	115
2025 Q2	$4.21M	Buy	50,800 +3,322	+7%	+$265K	0.36%	73
2025 Q1	$3.85M	Buy	47,478 +32,434	+216%	+$2.9M	0.41%	72
2024 Q4	$1.35M	Buy	+15,044	New	+$1.46M	0.18%	139

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Crédit Industriel et Commercial's XBI Position: Q2 2026 in Review

Crédit Industriel et Commercial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 67% in Q2 2026, selling an estimated $3.25M and leaving 11,590 shares worth $1.83M. The position accounts for 0.12% of the portfolio, ranked #160.

Crédit Industriel et Commercial first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.55M in Q1 2026. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Crédit Industriel et Commercial held 11,590 shares of State Street SPDR S&P Biotech ETF worth $1.83M as of Q2 2026.
Crédit Industriel et Commercial sold 24,043 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.25M.
State Street SPDR S&P Biotech ETF made up 0.12% of Crédit Industriel et Commercial's portfolio in Q2 2026, its #160 holding.
Crédit Industriel et Commercial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
Crédit Industriel et Commercial's State Street SPDR S&P Biotech ETF position peaked at $4.55M in Q1 2026.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.